BRPI0415242A - microgránulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes - Google Patents
microgránulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estesInfo
- Publication number
- BRPI0415242A BRPI0415242A BRPI0415242-5A BRPI0415242A BRPI0415242A BR PI0415242 A BRPI0415242 A BR PI0415242A BR PI0415242 A BRPI0415242 A BR PI0415242A BR PI0415242 A BRPI0415242 A BR PI0415242A
- Authority
- BR
- Brazil
- Prior art keywords
- biloba extract
- making
- gingko biloba
- containing gingko
- gradual release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Abstract
"MICROGRANULOS DE LIBERAçãO GRADUAL CONTENDO EXTRATO DE GINGKO BILOBA E O PROCESSO PARA FABRICAR ESTES". A presente invenção refere-se a uma nova formulação de fármaco herbal estável sob a forma de microgrânulos de liberação gradual contendo extrato de Gingko Biloba bem como o processo para fabricar esta.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03292512 | 2003-10-10 | ||
EP03292512.5 | 2003-10-10 | ||
PCT/IB2004/003542 WO2005034923A1 (en) | 2003-10-10 | 2004-10-11 | Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0415242A true BRPI0415242A (pt) | 2006-12-12 |
BRPI0415242B1 BRPI0415242B1 (pt) | 2017-06-27 |
BRPI0415242B8 BRPI0415242B8 (pt) | 2021-05-25 |
Family
ID=34429540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0415242A BRPI0415242B8 (pt) | 2003-10-10 | 2004-10-11 | microgrânulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes |
Country Status (9)
Country | Link |
---|---|
US (1) | US7569236B2 (pt) |
EP (1) | EP1689373B1 (pt) |
JP (1) | JP5171038B2 (pt) |
KR (1) | KR101148734B1 (pt) |
CN (1) | CN1874764B (pt) |
BR (1) | BRPI0415242B8 (pt) |
CA (1) | CA2541578C (pt) |
MX (1) | MXPA06003942A (pt) |
WO (1) | WO2005034923A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230828B1 (en) | 1999-10-29 | 2018-08-28 | Euro Celtique Sa | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
CN101317825A (zh) | 2000-10-30 | 2008-12-10 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
JP2007254339A (ja) * | 2006-03-22 | 2007-10-04 | Takasago Internatl Corp | ロックイン型粉末 |
FR2938430B1 (fr) * | 2008-11-14 | 2011-05-20 | Debregeas Et Associes Pharma | Granules a base de plantes |
AU2011253216B2 (en) * | 2010-05-11 | 2016-10-20 | Cima Labs Inc. | Alcohol-resistant formulations |
MX2012012991A (es) | 2010-05-11 | 2012-11-30 | Cima Labs Inc | Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol. |
CH704253A1 (de) * | 2010-12-21 | 2012-06-29 | Mepha Gmbh | Pharmazeutische Zusammensetzung enthaltend pflanzliche Wirkstoffe. |
CN105435236A (zh) * | 2015-12-04 | 2016-03-30 | 中国林业科学研究院林产化学工业研究所 | 一种银杏抗性淀粉微球的制备方法 |
WO2017146286A1 (ko) * | 2016-02-26 | 2017-08-31 | 에스케이케미칼주식회사 | 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제 |
KR101992394B1 (ko) | 2016-03-07 | 2019-06-24 | 에스케이케미칼 주식회사 | 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제 |
KR101992404B1 (ko) | 2016-03-07 | 2019-06-24 | 에스케이케미칼 주식회사 | 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제 |
JP2023544420A (ja) | 2020-10-05 | 2023-10-23 | エックスダブリューファーマ リミテッド | ガンマ-ヒドロキシ酪酸誘導体の調節放出組成物 |
EP4308086A1 (en) | 2021-03-19 | 2024-01-24 | XWPharma Ltd. | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1443063A (fr) | 1963-08-27 | 1966-06-24 | Key Pharma | Préparation contenant de la théophylline |
AT336190B (de) | 1974-07-23 | 1977-04-25 | Hurka Wilhelm | Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes |
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
FR2613223B1 (fr) | 1987-04-03 | 1991-09-13 | Biogalenique Laboratoires | Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation |
JP2515802B2 (ja) * | 1987-05-26 | 1996-07-10 | 大正製薬株式会社 | 安定化製剤の製造方法 |
FR2616068A1 (fr) | 1987-06-04 | 1988-12-09 | Phytland Sa Laboratoires | Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises |
FR2623714B1 (fr) | 1987-11-26 | 1990-04-20 | Ethypharm Sa | Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu |
US5876758A (en) | 1989-08-04 | 1999-03-02 | Lvmh Recherche | Solid complex particles comprising a biologically active solid substance, mode of preparation and compositions for topical use containing them and intended to treat biological surfaces |
FR2685635B1 (fr) | 1991-12-27 | 1995-06-30 | Lvmh Rech | Particules solides complexes comprenant une substance solide biologiquement active, leur mode de preparation et compositions a usage topique les renfermant destinees au traitement de surfaces biologiques. |
US5104661A (en) | 1989-08-14 | 1992-04-14 | Technology Unlimited, Inc. | Reverse loading of liposomes |
JP2542122B2 (ja) | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | 球状核、球形顆粒およびその製造方法 |
FR2682874B1 (fr) | 1991-10-24 | 1993-12-10 | Rinrone Ets | Procede pour la preparation d'un extrait de principes actifs sous forme seche adsorbable et microgranules adsorbables ainsi obtenus. |
FR2692146B1 (fr) | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
US5387390A (en) * | 1993-04-26 | 1995-02-07 | Atoma International Inc. | Method of molding a vehicle door panel with a soft arm rest |
IL110035A0 (en) | 1994-06-16 | 1994-10-07 | Tapuach Natural Technologies 1 | Homeopathic formulations |
FR2721512A1 (fr) | 1994-06-28 | 1995-12-29 | Maurice Jacob | Formulation et procédé de préparation de sphéroïdes à base de solutions d'origine végétale. |
DE19515971A1 (de) * | 1995-05-02 | 1996-11-07 | Bayer Ag | Kombinationspräparate mit vaskulärer Wirkung |
FR2737134B1 (fr) | 1995-07-27 | 1998-05-29 | Bionatec Sarl | Procede de fabrication de granules et granules ainsi obtenus |
DE19539361A1 (de) | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
ES2175130T3 (es) | 1995-10-27 | 2002-11-16 | Givaudan Sa | Granulado de aromas. |
FR2742660B1 (fr) | 1995-12-22 | 1998-04-03 | Ethypharm Lab Prod Ethiques | Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif |
US6120621A (en) * | 1996-07-08 | 2000-09-19 | Alcan International Limited | Cast aluminum alloy for can stock and process for producing the alloy |
EP0935417B1 (en) | 1996-10-16 | 2009-05-06 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
FR2759293B1 (fr) | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
FR2771291B1 (fr) | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
FR2769524B1 (fr) | 1998-01-06 | 1999-12-31 | Ethypharm Lab Prod Ethiques | Dispositif d'enrobage pour granules a absorber par voie orale |
FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
FR2774910B1 (fr) | 1998-02-16 | 2001-09-07 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques |
US6030621A (en) | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
AU764469B2 (en) * | 1999-01-29 | 2003-08-21 | Disphar International B.V. | Pharmaceutical compositions |
FR2790668B1 (fr) * | 1999-03-12 | 2002-07-26 | D B F | Granules contenant une substance vegetale et leur procede de preparation |
PT1178778E (pt) * | 1999-05-17 | 2006-06-30 | D B F | Granulos que contem uma substancia vegetal e o seu procedimento de preparacao |
US6340478B1 (en) | 1999-06-07 | 2002-01-22 | Bio Dar Ltd. | Microencapsulated and controlled-release herbal formulations |
CA2378052C (en) * | 1999-08-12 | 2010-03-23 | Katy Drieu | Use of ginkgo extract |
CN1177603C (zh) * | 2002-03-22 | 2004-12-01 | 山西亚宝药业集团股份有限公司 | 银杏叶缓释片 |
ITMI20020990A1 (it) * | 2002-05-10 | 2003-11-10 | Indena Spa | Formulazioni utili nel trattamento dell'impotenza maschile e femminile |
JP4528490B2 (ja) * | 2002-06-25 | 2010-08-18 | 和光化学株式会社 | ギンコライド−aを含有する抗不安剤 |
DE10250543A1 (de) * | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
PL1667665T3 (pl) * | 2003-09-03 | 2009-06-30 | Pharmaton Sa | Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalniania |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
-
2004
- 2004-10-11 US US10/574,923 patent/US7569236B2/en not_active Expired - Fee Related
- 2004-10-11 JP JP2006530765A patent/JP5171038B2/ja not_active Expired - Fee Related
- 2004-10-11 CA CA2541578A patent/CA2541578C/en active Active
- 2004-10-11 CN CN2004800319543A patent/CN1874764B/zh active Active
- 2004-10-11 MX MXPA06003942A patent/MXPA06003942A/es active IP Right Grant
- 2004-10-11 KR KR1020067008797A patent/KR101148734B1/ko not_active IP Right Cessation
- 2004-10-11 EP EP04791759.6A patent/EP1689373B1/en active Active
- 2004-10-11 WO PCT/IB2004/003542 patent/WO2005034923A1/en active Application Filing
- 2004-10-11 BR BRPI0415242A patent/BRPI0415242B8/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN1874764B (zh) | 2012-08-01 |
BRPI0415242B1 (pt) | 2017-06-27 |
CA2541578C (en) | 2014-03-25 |
JP5171038B2 (ja) | 2013-03-27 |
US7569236B2 (en) | 2009-08-04 |
CN1874764A (zh) | 2006-12-06 |
CA2541578A1 (en) | 2005-04-21 |
EP1689373B1 (en) | 2019-04-03 |
EP1689373A1 (en) | 2006-08-16 |
KR101148734B1 (ko) | 2012-07-05 |
WO2005034923A1 (en) | 2005-04-21 |
JP2007508292A (ja) | 2007-04-05 |
MXPA06003942A (es) | 2006-07-05 |
US20070009598A1 (en) | 2007-01-11 |
KR20060115869A (ko) | 2006-11-10 |
BRPI0415242B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0415242A (pt) | microgránulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes | |
BRPI0407430A (pt) | Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa | |
CY2013016I2 (el) | Διαλυμα ακετονης διμεθοξυ δοσεταξελης και η διαδικασια παρασκευης του | |
HN2008000188A (es) | 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion | |
DE602005012289D1 (de) | Abgabevehikel mit nanoteilchen | |
HN2004000490A (es) | Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente | |
CY2013002I1 (el) | 8-[3-αμινο-πιπεριδιν-1-υλο]-ξανθινες, παραγωγη αυτων και χρηση τους ως φαρμακων | |
DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
ATE407921T1 (de) | Neues verfahren zur herstellung und eine neue kristallform des agomelatins sowie pharmazeutische zusammensetzungen, die diese enthalten | |
NI200500164A (es) | Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso. | |
IS8105A (is) | Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum | |
DE602005011939D1 (de) | Verfahren zur Herstellung von Polyphenol angereicherten Zusammensetzungen aus Kakaoschale | |
DE112006001414A5 (de) | Gehäusekörper und Verfahren zu dessen Herstellung | |
ATE411308T1 (de) | Alpha-kristallform von strontiumranelat, verfahren zu ihrer herstellung und dieser enthaltende pharmazeutische zusammensetzungen | |
DE502006008551D1 (de) | Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
DE602004012812D1 (de) | Verfahren zur Herstellung von Teeextrakt | |
DOP2006000091A (es) | Método mejorado para preparar extractos de ginkgo que tienen un contenido bajo de 4'-o-metil piridoxina y/o biflavonas | |
ATE548349T1 (de) | In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung | |
IL184697A (en) | Diclofenac Injection Composition, Process for its Preparation and Use for Medication and Pain Relief and / or Inflammation | |
CR8149A (es) | Comprimidos que contienen enrofloxacino y saborizantes y/o aromatizantes | |
ATA14022003A (de) | Verfahren zur herstellung cellulosischer formkörper | |
CR9231A (es) | Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion | |
AR051941A1 (es) | Formas de dosificacion que tienen una superficie con microrelieves y metodos y aparato para su producion | |
DE602005002138D1 (de) | Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 9/50, 36/16; A61P 25/28 Ipc: A61K 9/50 (2011.01), A61K 36/16 (2011.01), A61P 25 |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |